Regional
MEP (Medical Emergency Partnership) in partnership with SSM Health
Drugs and doses47
A–C Acetaminophen, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Buprenorphine, Calcium Chloride, Calcium Gluconate, Cefazolin10
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 15 mg/kg (max 1000 mg) | IV/PO | not captured | standing | page 128 |
| Fever | peds | 15 mg/kg (max 1000 mg) | IV/PO | not captured | standing | page 128 |
| Other | adult | 15 mg/kg (max 1000 mg) | IV/PO | not captured | standing | page 128 |
| Other | peds | 15 mg/kg (max 1000 mg) | IV/PO | not captured | standing | page 128 |
| Mild to moderate pain | adult | 15 mg/kg (max 1000 mg) | IV/PO | not captured | standing | page 128 |
| Mild to moderate pain | peds | 15 mg/kg (max 1000 mg) | IV/PO | not captured | standing | page 128 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 0.2 mg/kg (max 12 mg) | IV/IO | not captured | standing | page 129 |
| Narrow-complex tachycardia | peds | 0.2 mg/kg (max 12 mg) | IV/IO | not captured | standing | page 129 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB/MDI | not captured | standing | page 130 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB/MDI | not captured | standing | page 130 |
| Hyperkalemia | adult | 10 mg | NEB | not captured | standing | page 130 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 5 mg/kg (max 300 mg) | IV/IO | not captured | standing | page 131 |
| Cardiac arrest | peds | 5 mg/kg (max 300 mg) | IV/IO | not captured | standing | page 131 |
| Narrow-complex tachycardia | adult | 5 mg/kg (max 150 mg) | IV/IO | not captured | standing | page 131 |
| Narrow-complex tachycardia | peds | 5 mg/kg (max 150 mg) | IV/IO | not captured | standing | page 131 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 132 |
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 132 |
| STEMI | adult | 324 mg | PO | not captured | standing | page 132 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 0.02 mg/kg (max 1 mg) | IV/IO | not captured | standing | page 133 |
| Bradycardia | peds | 0.02 mg/kg (max 1 mg) | IV/IO | not captured | standing | page 133 |
| Organophosphate poisoning | adult | 2 mg | IV/IO/IM | not captured | standing | page 133 |
| Organophosphate poisoning | peds | 2 mg | IV/IO/IM | not captured | standing | page 133 |
Buprenorphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 16 mg | SL | not captured | standing | page 135 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 20 mg/kg | IV/IO | not captured | standing | page 36 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV/IO | not captured | standing | page 36 |
| Bradycardia | adult | 20 mg/kg | IV/IO | not captured | standing | page 35 |
| Bradycardia | peds | 20 mg/kg | IV/IO | not captured | standing | page 35 |
| Cardiac arrest | adult | 20 mg/kg | IV/IO | not captured | standing | page 36 |
| Cardiac arrest | peds | 20 mg/kg | IV/IO | not captured | standing | page 36 |
| Other | adult | 20 mg/kg | IV/IO | not captured | standing | page 134 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | page 134 |
| Narrow-complex tachycardia | adult | 20 mg/kg | IV/IO | not captured | standing | page 41 |
| Narrow-complex tachycardia | peds | 20 mg/kg | IV/IO | not captured | standing | page 41 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 60 mg/kg | IV/IO | not captured | standing | page 36 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 60 mg/kg | IV/IO | not captured | standing | page 36 |
| Bradycardia | adult | 60 mg/kg | IV/IO | not captured | standing | page 35 |
| Bradycardia | peds | 60 mg/kg | IV/IO | not captured | standing | page 35 |
| Cardiac arrest | adult | 100 mg/kg | IV/IO | not captured | standing | page 36 |
| Cardiac arrest | peds | 100 mg/kg | IV/IO | not captured | standing | page 36 |
| Other | adult | 60 mg/kg | IV/IO | not captured | standing | page 134 |
| Other | peds | 60 mg/kg | IV/IO | not captured | standing | page 134 |
| Narrow-complex tachycardia | adult | 60 mg/kg | IV/IO | not captured | standing | page 41 |
| Narrow-complex tachycardia | peds | 60 mg/kg | IV/IO | not captured | standing | page 41 |
Cefazolin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 35 mg/kg | IV/IO | not captured | standing | page 72 |
| Trauma / hemorrhage | peds | 35 mg/kg | IV/IO | not captured | standing | page 72 |
D–F Dexamethasone, Dextrose, Diltiazem, Diphenhydramine, Droperidol, Epinephrine, Etomidate, Fentanyl8
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.6 mg/kg | IV/IO/PO | not captured | standing | page 51 |
| Anaphylaxis | peds | 0.6 mg/kg | IV/IO/PO | not captured | standing | page 51 |
| Croup | adult | 0.6 mg/kg | IV/IO/PO | not captured | standing | page 40 |
| Croup | peds | 0.6 mg/kg | IV/IO/PO | not captured | standing | page 40 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 3 mL/kg | IV/IO | not captured | standing | page 61 |
| Hypoglycemia | peds | 3 mL/kg | IV/IO | not captured | standing | page 61 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 0.25 mg/kg | IV/IO | not captured | standing | page 41 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 1 mg/kg (max 50 mg) | IV/IO/IM/PO | not captured | standing | page 143 |
| Allergic reaction | peds | 1 mg/kg (max 50 mg) | IV/IO/IM/PO | not captured | standing | page 143 |
| Dystonic reaction | adult | 1 mg/kg (max 50 mg) | IV/IO/IM/PO | not captured | standing | page 143 |
| Dystonic reaction | peds | 1 mg/kg (max 50 mg) | IV/IO/IM/PO | not captured | standing | page 143 |
| Other | adult | 1 mg/kg (max 50 mg) | IV/IO/IM | not captured | standing | page 134 |
| Other | peds | 1 mg/kg (max 50 mg) | IV/IO/IM | not captured | standing | page 134 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 0.1 mg/kg (max 5 mg) | IV/IO | not captured | standing | page 53 |
| Agitation | adult | 0.2 mg/kg (max 10 mg) | IM | not captured | standing | page 53 |
| Nausea / vomiting | adult | 0.625 mg | IV/IO | not captured | standing | page 144 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | page 51 |
| Anaphylaxis | peds | 0.15–0.3 mg | IM | not captured | standing | page 51 |
| Asthma / bronchospasm | adult | 0.3–0.5 mg | IM | not captured | standing | page 40 |
| Asthma / bronchospasm | peds | 0.15–0.3 mg | IM | not captured | standing | page 40 |
| Bradycardia | adult | 2–12 mcg | IV/IO | not captured | standing | page 35 |
| Bradycardia | peds | 0.01 mg/kg (max 1 mg) | IV/IO | not captured | standing | page 35 |
| Cardiac arrest | adult | 0.01 mg/kg (max 1 mg) | IV/IO | not captured | standing | page 35 |
| Cardiac arrest | peds | 0.01 mg/kg (max 1 mg) | IV/IO | not captured | standing | page 35 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.3 mg/kg (max 30 mg) | IV/IO | not captured | standing | page 34 |
| RSI induction | peds | 0.3 mg/kg (max 30 mg) | IV/IO | not captured | standing | page 34 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.5–1 mcg/kg (max 100 mcg) | IV/IO/IM/IN | not captured | standing | page 39 |
| Mild to moderate pain | peds | 0.5–1 mcg/kg (max 100 mcg) | IV/IO/IM/IN | not captured | standing | page 39 |
| Procedural sedation | adult | 0.5–1 mcg/kg (max 100 mcg) | IV/IO/IM/IN | not captured | standing | page 33 |
| Procedural sedation | peds | 0.5–1 mcg/kg (max 100 mcg) | IV/IO/IM/IN | not captured | standing | page 33 |
G–L Glucagon, Hydromorphone, Hydroxocobalamin, Ibuprofen, Ipratropium, Ketamine, Ketorolac, Labetalol, Levetiracetam, Lidocaine, Lorazepam11
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 0.05 mg/kg (max 2 mg) | IV/IO | not captured | standing | page 36 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.05 mg/kg (max 2 mg) | IV/IO | not captured | standing | page 36 |
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | page 61 |
| Hypoglycemia | peds | 0.5 mg | IM | not captured | standing | page 61 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.02 mg/kg | IV/IO/IM | not captured | standing | page 67 |
| Mild to moderate pain | peds | 0.02 mg/kg | IV/IO/IM | not captured | standing | page 67 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 70 mg/kg | IV/IO | not captured | standing | page 56 |
| Cyanide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | page 56 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 10 mg/kg | PO | not captured | standing | page 58 |
| Fever | peds | 10 mg/kg | PO | not captured | standing | page 58 |
| Mild to moderate pain | adult | 10 mg/kg | PO | not captured | standing | page 58 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | page 58 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | page 40 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | page 40 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 4 mg/kg | IM | not captured | standing | page 53 |
| Agitation | peds | 4 mg/kg | IM | not captured | standing | page 53 |
| Mild to moderate pain | adult | 0.25 mg/kg | IV/IO/IM/IN | not captured | standing | page 67 |
| Mild to moderate pain | peds | 0.25 mg/kg | IV/IO/IM/IN | not captured | standing | page 67 |
| Procedural sedation | adult | 2 mg/kg | IV/IO | not captured | standing | page 33 |
| Procedural sedation | peds | 2 mg/kg | IV/IO | not captured | standing | page 33 |
| Seizure | adult | 2 mg/kg | IV/IO | not captured | standing | page 68 |
| Seizure | peds | 2 mg/kg | IV/IO | not captured | standing | page 68 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 0.5 mg/kg | IV/IO | not captured | standing | page 58 |
| Fever | adult | 1 mg/kg | IM | not captured | standing | page 58 |
| Fever | peds | 0.5 mg/kg | IV/IO | not captured | standing | page 58 |
| Fever | peds | 1 mg/kg | IM | not captured | standing | page 58 |
| Mild to moderate pain | adult | 0.5 mg/kg | IV/IO | not captured | standing | page 67 |
| Mild to moderate pain | adult | 1 mg/kg | IM | not captured | standing | page 67 |
| Mild to moderate pain | peds | 0.5 mg/kg | IV/IO | not captured | standing | page 67 |
| Mild to moderate pain | peds | 1 mg/kg | IM | not captured | standing | page 67 |
| Sepsis | adult | 0.5 mg/kg | IV/IO | not captured | standing | page 58 |
| Sepsis | adult | 1 mg/kg | IM | not captured | standing | page 58 |
| Sepsis | peds | 0.5 mg/kg | IV/IO | not captured | standing | page 58 |
| Sepsis | peds | 1 mg/kg | IM | not captured | standing | page 58 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20 mg | IV/IO | not captured | standing | page 47 |
Levetiracetam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Head injury / TBI | adult | 60 mg/kg | IV/IO | not captured | standing | page 72 |
| Head injury / TBI | peds | 60 mg/kg | IV/IO | not captured | standing | page 72 |
| Seizure | adult | 60 mg/kg | IV/IO | not captured | standing | page 68 |
| Seizure | peds | 60 mg/kg | IV/IO | not captured | standing | page 68 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 36 |
| Cardiac arrest | peds | 1.5 mg/kg | IV/IO | not captured | standing | page 36 |
| Mild to moderate pain | adult | 0.5 mg/kg | IO | not captured | standing | page 113 |
| Mild to moderate pain | peds | 0.5 mg/kg | IO | not captured | standing | page 113 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 161 |
| Agitation | adult | 0.2 mg/kg | IM | not captured | standing | page 161 |
| Agitation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 161 |
| Hyperthermia | adult | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 161 |
| Hyperthermia | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 161 |
| Nausea / vomiting | adult | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 161 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 161 |
| Other | adult | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 161 |
| Other | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 161 |
| Procedural sedation | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 161 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 161 |
| Seizure | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 161 |
| Seizure | adult | 0.2 mg/kg | IM | not captured | standing | page 161 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 161 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | page 161 |
M–O Magnesium Sulfate, Methylprednisolone, Midazolam, Naloxone, Nerve Agent Antidote Kit, Nitroglycerin, Norepinephrine, Olanzapine, Ondansetron, Oral Glucose, Oxymetazoline, Oxytocin12
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 50 mg/kg | IV/IO | not captured | standing | page 40 |
| Asthma / bronchospasm | peds | 50 mg/kg | IV/IO | not captured | standing | page 40 |
| COPD | adult | 50 mg/kg | IV/IO | not captured | standing | page 40 |
| COPD | peds | 50 mg/kg | IV/IO | not captured | standing | page 40 |
| Eclampsia / pre-eclampsia | adult | 10 g | IM | not captured | standing | page 47 |
| Eclampsia / pre-eclampsia | adult | 50 mg/kg | IV/IO | not captured | standing | page 47 |
| Eclampsia / pre-eclampsia | peds | 10 g | IM | not captured | standing | page 47 |
| Eclampsia / pre-eclampsia | peds | 50 mg/kg | IV/IO | not captured | standing | page 47 |
| VF / pulseless VT | adult | 50 mg/kg | IV/IO | not captured | standing | page 36 |
| VF / pulseless VT | peds | 50 mg/kg | IV/IO | not captured | standing | page 36 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 2 mg/kg | IV/IO | not captured | standing | page 163 |
| Allergic reaction | peds | 2 mg/kg | IV/IO | not captured | standing | page 163 |
| Anaphylaxis | adult | 2 mg/kg | IV/IO | not captured | standing | page 163 |
| Anaphylaxis | peds | 2 mg/kg | IV/IO | not captured | standing | page 163 |
| Other | adult | 2 mg/kg | IV/IO | not captured | standing | page 40 |
| Other | peds | 2 mg/kg | IV/IO | not captured | standing | page 40 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 164 |
| Agitation | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 164 |
| Agitation | adult | 0.2 mg/kg | IM/IN | not captured | standing | page 164 |
| Agitation | adult | 0.2 mg/kg | IM/IN | not captured | standing | page 164 |
| Agitation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 164 |
| Agitation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 164 |
| Agitation | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 164 |
| Agitation | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 164 |
| Hyperthermia | adult | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 164 |
| Hyperthermia | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 164 |
| Nausea / vomiting | adult | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 164 |
| Nausea / vomiting | adult | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 164 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 164 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 164 |
| Other | adult | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 164 |
| Other | adult | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 164 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 164 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 164 |
| Seizure | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 164 |
| Seizure | adult | 0.2 mg/kg | IM/IN | not captured | standing | page 164 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 164 |
| Seizure | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 164 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–2 mg | IV/IO/IN | not captured | standing | page 66 |
| Opioid overdose | peds | 0.4–2 mg | IV/IO/IN | not captured | standing | page 66 |
Nerve Agent Antidote Kit
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Organophosphate poisoning | adult | 2.1 mg | IM | not captured | standing | page 66 |
| Organophosphate poisoning | peds | 2.1 mg | IM | not captured | standing | page 66 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 39 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 40 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 4–16 mcg | IV/IO | not captured | standing | page 62 |
Olanzapine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 10 mg | PO | not captured | standing | page 169 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 0.15 mg/kg (max 4 mg) | IV/IO/ODT | not captured | standing | page 170 |
| Nausea / vomiting | peds | 0.15 mg/kg (max 4 mg) | IV/IO/ODT | not captured | standing | page 170 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15 g | PO | not captured | standing | page 61 |
| Hypoglycemia | peds | 15 g | PO | not captured | standing | page 61 |
Oxymetazoline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 spray | IN | not captured | standing | page 172 |
| Other | peds | 2 spray | IN | not captured | standing | page 172 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 unit | IM | not captured | standing | page 46 |
P–R Rocuronium1
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1 mg/kg | IV/IO | not captured | standing | page 34 |
| RSI induction | peds | 1 mg/kg | IV/IO | not captured | standing | page 34 |
S–Z Sodium Bicarbonate, Succinylcholine, Tetracaine, Tranexamic Acid, Vecuronium5
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 1 mEq/kg | IV/IO | not captured | standing | page 72 |
| Crush injury | peds | 1 mEq/kg | IV/IO | not captured | standing | page 72 |
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | page 35 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | page 35 |
| Tricyclic overdose | adult | 1 mEq/kg | IV/IO | not captured | standing | page 36 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | page 36 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | page 34 |
| RSI induction | peds | 2 mg/kg | IV/IO | not captured | standing | page 34 |
Tetracaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 1–2 drop | OPH | not captured | standing | page 72 |
| Mild to moderate pain | peds | 1–2 drop | OPH | not captured | standing | page 72 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 15 mg/kg | IV/IO | not captured | standing | page 46 |
| Other | adult | 500 mg | NEB | not captured | standing | page 59 |
| Other | peds | 250 mg | NEB | not captured | standing | page 59 |
| Trauma / hemorrhage | adult | 30 mg/kg | IV/IO | not captured | standing | page 38 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV/IO | not captured | standing | page 38 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.1 mg/kg (max 10 mg) | IV/IO | not captured | standing | page 34 |
| RSI induction | peds | 0.1 mg/kg (max 10 mg) | IV/IO | not captured | standing | page 34 |
Cite this
MEP (Medical Emergency Partnership) in partnership with SSM Health, United States EMS Protocol Census. 205 dose entries, effective 2026-04-01.
https://protoquiz.com/census/agencies/mep-in-partnership-with-ssm-health/
The census is free and not for sale. Only public agencies are named.